But A Lot of Green Today in Diagnostics and Tools
The NASDAQ (4030)and the S&P (1787) are up about 0.7% but biotech stocks are lagging with the IBB ($216) up only 0.33%. Momentum in biopharmaceutical stocks has been easing since a late November move around the $225 mark. Stock distribution predominates in December. The IBB is still in the middle of its upward channel while the PBE ($35.68) is trending to the lower end of its channel. Large cap drugs stocks are flat to mixed.
Several Rayno Life Science stocks are movers today with diagnostics and tools showing strength over biopharmaceuticals. Volume is robust.
Alere (ALR) is up 3.4%
Cepheid is up 1.8%
Cubist (CBST) is up 6.3% on positive news for its Phase 3 antibiotic for abdominal infections.
Illumina (ILMN) is up 1.5%
Immunogen (IMGN) is up 1.8%
Nanosphere (NSPH) is up 3.8%
NanoString (NSTG) is up 1.3%.
Qiagen (QGEN) is up 1.9%